Banu Açmaz

Dr. Banu Açmaz


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
YSYasin Sahinturk
Yasin Sahinturk
GKGokhan Koker
Gokhan Koker
Nizameddin KocaNizameddin Koca
Nizameddin Koca
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
IDIsmail Demir
Ismail Demir
SUSeyit Uyar
Seyit Uyar
Background/Aims: This awareness study aimed to determine the ultrasound (US) examination rates in relation to US-confirmed metabolic dysfunction-associated fatty liver disease (MAFLD) diagnosis in internal medicine outpatients with type 2 diabetes (T2D) across Türkiye. Materials and Methods: A total of 6283 T2D patients were included in this multicenter retrospective cohort study conducted at 17 internal medicine clinics across Türkiye. The presence and indications for US performed within the last 3 years were recorded along with US-confirmed MAFLD rates, laboratory findings on the day of US, and referral rates. Fibrosis-4 (FIB-4) index was calculated to estimate the risk of advanced liver fibrosis (FIB-4 index ≥ 1.3). Results: Overall, 1731 (27.6%) of 6283 patients had US examination, which revealed MAFLD diagnosis in 69.9% of cases. In addition, 24.4% of patients with US-confirmed MAFLD were at risk of advanced fibrosis (FIB-4 index ≥ 1.3), and the referral rate was 15.5%. Conclusion: In conclusion, our findings emphasize an insufficient MAFLD awareness among clinicians and the likelihood of most of T2D patients to be at risk of living with an unknown status regarding their MAFLD and advanced fibrosis risk. Cite this article as: Şahintürk Y, Köker G, Koca N, et al. Metabolic dysfunction-associated fatty liver disease and fibrosis status in patients with type 2 diabetes treated at internal medicine clinics: Türkiye DAHUDER awareness of fatty liver disease (TR-DAFLD) study. Turk J Gastroenterol. 2024;35(8):643-650.

1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
BABanu Açmaz
Banu Açmaz
SBSami Bahçebaşı
Sami Bahçebaşı
EAErdem Aydın
Erdem Aydın
ŞYŞeyma Yıldız
Şeyma Yıldız
İBİfakat İrem Biçer
İfakat İrem Biçer
Introduction: Obesity, particularly morbid obesity, is associated with significant metabolic alterations such as insulin resistance and compensatory hyperinsulinemia. These pathophysiological changes may influence the performance and interpretation of glycemic diagnostic tools, including the oral glucose tolerance test (OGTT) and glycated hemoglobin (HbA1c). This study is aimed at comparing the diagnostic profiles of OGTT and HbA1c across BMI categories, with a specific focus on morbid obesity and the potential role of elevated insulin levels in test discrepancies. Materials and Methods: This retrospective study included 1031 patients who were classified into nonobese, obese, and morbidly obese groups based on body mass index (BMI). All participants underwent assessment of glycemic status, lipid profile, and related metabolic parameters. Results: Of the study population, 86.8% were female. Based on BMI classification, 56.5% were obese, 35.8% morbidly obese, and 7.8% nonobese. The prevalence of dysglycemia (prediabetes + diabetes) was 43.1% according to HbA1c and 30.9% according to OGTT. Dysglycemia was significantly more frequent in the morbidly obese group by HbA1c ( p < 0.001), while OGTT showed no significant intergroup difference ( p = 0.117). The agreement between methods was low ( κ = 0.326). HbA1c, insulin, HOMA‐IR, CRP, and triglyceride levels increased with BMI. Insulin‐related parameters were higher among HbA1c‐defined dysglycemic individuals. Discussion: HbA1c may be more sensitive in identifying early metabolic disturbances, particularly during the compensatory phase involving hyperinsulinemia. Elevated insulin levels may attenuate glucose response during OGTT, potentially reducing its diagnostic sensitivity.

28 December 2025 in Journal of Clinical Densitometry
Verified
Journal Article
Closed access
SBSami Bahçebaşı
Sami Bahçebaşı
BABanu Açmaz
Banu Açmaz
ASAhmet Savranlar
Ahmet Savranlar

6 May 2026 in Life
Verified
Journal Article
Open access
PDF file
BABanu Açmaz
Banu Açmaz
VBVasfiye Nihan Burcek
Vasfiye Nihan Burcek
MLMahmut Burak Lacin
Mahmut Burak Lacin
NBNazmiye Serap Biçer
Nazmiye Serap Biçer
HHHilal Horozoğlu
Hilal Horozoğlu
YSYasin Simsek
Yasin Simsek
Introduction: Diabetes mellitus (DM) is associated with multiple systemic complications, yet its effects on respiratory muscle structure remain insufficiently characterized. This study aimed to evaluate diaphragmatic morphology in patients with type 2 DM and to determine whether glycemic control is associated with diaphragmatic thickness. Methods: A total of 120 participants were enrolled, including 60 patients with type 2 DM and 60 healthy controls. Demographic, biochemical, and diaphragmatic ultrasound parameters were assessed, including right and left diaphragm thickness (DT) during inspiration and expiration, diaphragmatic excursion (DE), and costophrenic angle (CPA). All patients with DM underwent electromyography for evaluation of peripheral neuropathy. Diabetic participants were further stratified according to glycemic control using an HbA1c threshold of 7%. Correlation analyses and multivariable linear regression models adjusted for age and body mass index (BMI) were performed to examine the association between HbA1c and diaphragmatic parameters. Results: Compared with controls, patients with DM were older and had higher fasting glucose levels but lower total cholesterol, whereas BMI and other biochemical parameters were comparable. Peripheral neuropathy was identified in 28.3% of patients with DM, but was not associated with significant differences in DT, DE, or CPA. In the three-group analysis, right and left DT measured during both inspiration and expiration differed significantly among well-controlled DM, poorly controlled DM, and control groups, whereas DE and CPA remained similar. Within the DM cohort, higher HbA1c levels were significantly associated with lower right and left DT values. These inverse associations remained independent after adjustment for age and BMI, while no independent associations were observed between HbA1c and either DE or CPA. Conclusions: Poorer glycemic control was associated with reduced diaphragmatic thickness in patients with T2DM. Ultrasonographic assessment may offer a non-invasive approach for detecting early respiratory muscle involvement, although its clinical and functional relevance should be validated in future prospective studies.

1 January 2025 in Journal of Clinical Practice and Research
Verified
Journal Article
Open access
PDF file
FOFATMA Ozdemir
FATMA Ozdemir
GAGokhan Acmaz
Gokhan Acmaz
AYArzu Yay
Arzu Yay
HAHulya Akgun
Hulya Akgun
OCOzge Mat Cengiz
Ozge Mat Cengiz
KSKevser Sakarya
Kevser Sakarya
Objective: Ovarian hyperstimulation syndrome (OHSS) is an undesired outcome of controlled ovarian stimulation, commonly used in infertility treatment during in vitro fertilization and intrauterine insemination cycles. This study aimed to investigate whether retinoic acid and bevacizumab have an effect on the prevention of OHSS. Materials and Methods: A hyperstimulation model was created using 40 Wistar albino rats, each 22 days old. The rats were divided into four groups. Group 1 was the negative control group, Group 2 was the positive control group, Group 3 was the bevacizumab-administered group after ovarian hyperstimulation, and Group 4 was the retinoic acid-administered group after ovarian hyperstimulation. Serum estradiol and vascular endothelial growth factor (VEGF) levels were evaluated. Peritoneal fluid was collected using a syringe, and the presence of peritoneal fluid was recorded observationally. Hematoxylin and eosin staining and Masson’s trichrome staining were performed on the ovaries. Immunohistochemical staining for VEGF and estrogen receptors was conducted. Results: Retinoic acid treatment significantly reduced peritoneal fluid and inhibited fluid leakage, whereas bevacizumab treatment resulted in a slight reduction of peritoneal fluid. The number of tertiary and secondary follicles remained unaffected by both bevacizumab and retinoic acid treatment. However, the number of primary follicles significantly decreased in the bevacizumab and retinoic acid treatment groups. Retinoic acid treatment significantly reduced estrogen receptor (ER) in the stromal compartment. Conclusion: Both retinoic acid and bevacizumab appear to be effective in treating OHSS. Additionally, retinoic acid and bevacizumab influence the initial stages of follicular development. Future studies are essential to determine the optimal dosage and timing for these therapeutic agents.

10 December 2022 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
FOFATMA Ozdemir
FATMA Ozdemir
BABanu Açmaz
Banu Açmaz
GAGokhan Acmaz
Gokhan Acmaz
IMİptisam Müderri̇s
İptisam Müderri̇s
SMSelçuk Mistik
Selçuk Mistik
Objective: There is a close association between obesity and menstrual irregularity. This study aims to investigate lipoid tissue accumulation between overweight or obese premenopausal patients with endometrial hyperplasia and with benign pathologic lesions via using the bioimpedance method.Materials and Methods: Obese or overweight volunteers with abnormal uterine bleeding were examined. Eighty-eight volunteers meet the inclusion criteria. We obtained fat mass, fat percentage and impedance of body parts by using Multi-Frequency Body Composition Analyzer. Blood lipid profile and ultrasonographic measurement of endometrial thickness were also performed. Results: 33 volunteers were in the hyperplasia group and 55 were in the control group. 28 of the 33 volunteers (84.8%) had at least one increased fatty acid. 41 of the 55 patients (74.5%) had at least one increased fatty acid in the control group. Total cholesterol levels are higher in the hyperplasia group than in the control group (p=0.006). There was no significant difference between the groups for bioimpedance analyses. Conclusion: Hyperlipidemia remains an important factor that contributes to endometrial pathologies. Serum cholesterols were significantly high in the endometrial hyperplasia group. Rather than lipoid tissue distribution, increased cholesterol may contribute to gynecologic pathology occurrence in obese individuals complicated with endometrial hyperplasia.